Literature DB >> 20843232

Fusobacterium nucleatum binding to complement regulatory protein CD46 modulates the expression and secretion of cytokines and matrix metalloproteinases by oral epithelial cells.

Hayette Mahtout1, Fatiha Chandad, Jose M Rojo, Daniel Grenier.   

Abstract

BACKGROUND: Periodontitis is a chronic inflammatory disease that results in the destruction of the supporting tissues of the teeth. Gingival epithelial cells are an important mechanical barrier and participate in the host inflammatory response to periodontopathogens. The aim of the present study is to investigate the capacity of Fusobacterium nucleatum to bind to the complement regulatory protein CD46 expressed by oral epithelial cells and to determine the impact of the binding on the gene expression and protein secretion of interleukin (IL)-6, IL-8, and matrix metalloproteinase (MMP)-9 by oral epithelial cells.
METHODS: Binding of recombinant human CD46 to the surface of F. nucleatum was demonstrated by immunologic assays. After stimulation of oral epithelial cells with F. nucleatum, gene expression was determined by real-time polymerase chain reaction analysis while protein secretion was monitored by enzyme-linked immunosorbent assays.
RESULTS: Heat and protease treatments of bacterial cells reduced CD46 binding. F. nucleatum-bound CD46 mediated the cleavage of C3b in the presence of factor I. Stimulating oral epithelial cells with F. nucleatum at a multiplicity of infection of 50 resulted in a significant upregulation of the gene expression and protein secretion of IL-6, IL-8, and MMP-9 by oral epithelial cells. However, pretreating the epithelial cells with an anti-CD46 polyclonal antibody attenuated the production of IL-6, IL-8, and MMP-9 in response to F. nucleatum. Such an inhibitory effect was not observed with non-specific antibodies.
CONCLUSIONS: The present study demonstrates that F. nucleatum can bind the complement regulatory protein CD46. The interaction of F. nucleatum with epithelial cell surface CD46 may contribute to increasing the levels of proinflammatory mediators and MMPs in periodontal sites and consequently modulate tissue destruction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20843232     DOI: 10.1902/jop.2010.100458

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  6 in total

1.  A cocoa (Theobroma cacao L.) extract impairs the growth, virulence properties, and inflammatory potential of Fusobacterium nucleatum and improves oral epithelial barrier function.

Authors:  Amel Ben Lagha; Patricia Maquera Huacho; Daniel Grenier
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

Review 2.  Complement regulator CD46: genetic variants and disease associations.

Authors:  M Kathryn Liszewski; John P Atkinson
Journal:  Hum Genomics       Date:  2015-06-10       Impact factor: 4.639

3.  Low Abundance Fusobacterium Nucleatum Supports Early Pregnancy Development - An In Vitro Study.

Authors:  Martha Heusler; Rebekka Einenkel; Jens Ehrhardt; Damián Oscar Muzzio; Marek Zygmunt
Journal:  Front Immunol       Date:  2021-08-31       Impact factor: 7.561

4.  CD46 Genetic Variability and HIV-1 Infection Susceptibility.

Authors:  Carmen Serrano-Rísquez; Mohamed Omar; María Amparo Gómez-Vidal; Luis Miguel Real; Juan Antonio Pineda; Antonio Rivero; Antonio Rivero-Juárez; Donald Forthal; Francisco J Márquez; Sergio Lo Caputo; Mario Clerici; Mara Biasin; Antonio Caruz
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

5.  Preterm Birth Is Correlated With Increased Oral Originated Microbiome in the Gut.

Authors:  Chunhua Yin; Jingrui Chen; Xuena Wu; Yeling Liu; Quan He; Ying Cao; Yi-E Huang; Sisun Liu
Journal:  Front Cell Infect Microbiol       Date:  2021-06-17       Impact factor: 5.293

6.  Pathways involved in the synergistic activation of macrophages by lipoteichoic acid and hemoglobin.

Authors:  Kathleen H Cox; Michelle E Cox; Virginia Woo-Rasberry; David L Hasty
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.